Immunoglobulin A (IgA) pemphigus is a rare autoimmune blistering disorder. Unlike other forms of pemphigus that are mediated by immunoglobulin G (IgG) autoantibodies, IgA pemphigus is caused predominantly by IgA antibodies that are directed against various adhesion molecules expressed by keratinocytes.

There are 4 subtypes of IgA pemphigus: (1) subcorneal pustular dermatosis (SPD), (2) intraepidermal neutrophilic (IEN), (3) IgA pemphigus foliaceus (PF), and (4) pemphigus vulgaris-like (PVe) IgA pemphigus, although clinical overlap among subtypes as well as with other autoimmune bullous dermatoses (eg, pemphigus vulgaris) has been reported. The PVe subtype is thought to be a type of pyodermatitis-pyostomatitis vegetans, which is associated with inflammatory bowel disease.

The SPD subtype is characterized by IgA autoantibodies directed against desmocollin 1. The remaining 3 subtypes are characterized by a heterogeneous group of autoantigens (including desmoglein 1 or desmoglein 3), as well as desmocollin 1, 2, and 3.

Epidemiological data on IgA pemphigus is limited. Studies suggest a slight predominance among women, with an average age of onset in the fifth decade, although the condition has been reported in patients ranging in age from 1 month to 94 years. The clinical phenotype of IgA pemphigus is generally milder than other forms of pemphigus, although significant morbidity may be observed on occasion.

Malignancies have been reported in around 20% of patients. Reported associated malignancies include IgA gammopathy, IgA multiple myeloma, peripheral T-cell lymphoma, chronic myeloid leukemia, diffuse large B-cell lymphoma, and, less commonly, solid organ malignancies (ie, lung, pancreatic, laryngeal, and ovarian). Malignancy can be diagnosed simultaneously with or after development of IgA pemphigus. Other associated conditions include gastrointestinal disorders (ie, ulcerative colitis, Crohn disease, and celiac disease), autoimmune diseases (ie, Sjögren syndrome, myasthenia gravis, and rheumatoid arthritis), and HIV infection.

Rare cases of IgA pemphigus following COVID-19 vaccination and immune checkpoint inhibitor administration have also been reported.